← Back to headlines
Arrowhead Stock Soars on Plozasiran Commercialization Progress
Arrowhead Pharmaceuticals (ARWR) stock reached a new high as its drug Plozasiran moves closer to expanded commercialization.
22 Jul, 19:05 — 22 Jul, 19:05
Sources
Showing 1 of 1 sources
Related Stories
Signs of depression in teenagers that parents often overlook
8h ago
74-year-old woman dies after being pulled unconscious from sea in Katerini, Greece
9h ago
August Depression: Psychologists Advise on Coping with End-of-Summer Sadness
9h ago
Heat Warnings Overlook Common Health Problems Exacerbated by Extreme Temperatures
9h ago